• NPPN and PhlebX Create Dash Health Through Merger

    by | Feb 27, 2025 11:59 am | Laboratories, MRI & Dialysis

    The National Phlebotomy Provider Network (NPPN) and PhlebX have announced plans to merge and form Dash Health, an advanced and comprehensive mobile diagnostic services platform. PhlebX provides at-home and on-site mobile phlebotomy services. Its fully digital technology platform and mobile phlebotomists empower clinical laboratories, physician... Read More »

  • Lohmann & Rauscher Acquires German Telemedicine Company OnlineDoctor

    by | Feb 27, 2025 11:54 am | eHealth

    Lohmann & Rauscher (L&R) announced on February 26 that it has acquired telemedicine company OnlineDoctor AG. This acquisition of a digital health start-up marks the first in L&R’s corporate history. OnlineDoctor is a provider of teledermatology in Switzerland and Germany, offering digital skin diagnoses by medical specialists.... Read More »

  • Montecito Medical Buys Three MOBs in Georgia

    by | Feb 26, 2025 3:42 pm | Other Services

    Montecito Medical Real Estate announced that it has acquired three medical office buildings in Georgia for an undisclosed price. The sale includes three medical outpatient buildings (MOBs) in the Atlanta MSA occupied by Aylo Health. The properties— in Ball Ground, Woodstock and Dawsonville, Georgia respectively—comprise a total of 52,726 square... Read More »

  • EXA Capital Acquires EHR Company PrecisionCare

    by | Feb 26, 2025 3:41 pm | eHealth

    EXA Capital has announced the acquisition of PrecisionCare for an undisclosed price. This acquisition strengthens EXA Capital’s presence in the healthcare technology sector and expands its portfolio into the space of care management solutions. Founded in New York in 1999, PrecisionCare provides a SaaS platform specializing in electronic health... Read More »

  • Hims & Hers Health Acquires Trybe Labs 

    by | Feb 25, 2025 10:32 am | Laboratories, MRI & Dialysis

    Hims & Hers Health, based in San Francisco, California, announced that it acquired Trybe Labs. The financial terms were not disclosed.  Trybe Labs, marketed as Sigmund NJ LLC, is an at-home lab testing facility. Its diagnostic testing abilities include a blood lancet, which is a less invasive alternative to traditional needles or dried... Read More »

Another Record Falls in Q1:15

by | Apr 4, 2015 3:19 pm | Behavioral Health Care, Biotechnology, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Physician Medical Groups, Rehabilitation

Now that the month is officially over, we can report our preliminary Q1:15 results—and it was another record breaker, at least for transactions. The 346 deals logged so far are 109% higher than the first quarter of 2014. You would think that the $104.7 billion in combined spending would set another record, but no. In Q1:09, we tracked $127.2 billion spent on 202 deals. That’s when Pfizer (NYSE: PFE) bought Wyeth for $68 billion.  Here’s the preliminary breakdown of Q1:15 — and remember, the spending is only for deals that disclosed prices. Read More »

Nikon Refocuses on Medical Devices

by | Mar 9, 2015 7:20 pm | Medical Devices

Nikon Corporation (T: 7731) is following its consumer electronics brethren, Canon, Inc. (NYSE: CAJ), FujiFilm (T: 4901), Olympus Corp. (T:7733), Pentax Corp. and Royal Philips (NYSE: PHG), into the health care industry. Last week it announced the acquisition of Optos. The $400 million price buys a Scottish medical device company that specializes in designing retinal-imaging machines used to test eyes and detect high blood press, and certain types of cancers.     Read More »

Cross-Border Merger in Medical Devices

by | Mar 2, 2015 6:59 pm | Medical Devices

With only four deals announced in January, it seemed as if M&A in the medical devices sector was drying up. Not quite, as 11 announcements surfaced in February. The largest came last week, as Sorin SpA (MIL: SRN) agreed to merge with Houston-based Cyberonics Inc. (NASDAQ: CYBX). The all-stock transaction produces a combined equity value of approximately $2.7 billion. If all goes according to plan, Cyberonics shareholders will own 54% of the new company upon closing, which translates to a purchase price of about $1.24 billion. The new company, still to be named, combines two global leaders in cardiac surgery and neuromodulation, and will be a major player in cardiac rhythm management,... Read More »